Co-Hosted Event
The PSMA & Beyond Conference, co-hosted by the University of California, Los Angeles (UCLA) and the University of California, San Francisco (UCSF), with support from the Prostate Cancer Foundation (PCF), will focus on the current and future use of PET imaging and radionuclide therapy, including presentations, panel discussions, and exhibits from invited speakers and stakeholders.

Welcome

It is with delight and pleasure that we invite and welcome you to the 2026 PSMA & Beyond Conference, in person or online.

The conference will include presentations and discussions on:

  • PSMA PET Imaging: We will delve into the intricacies of interpreting and reporting PSMA PET imaging, along with an evaluation of the current data supporting its use and its implications for patient care.
  • PSMA-Targeted Radioligand Therapy: Gain insights into patient selection criteria and the optimal management of PSMA-targeted radioligand therapy.
  • Combination Therapy and Future Trials: A critical review of the roles of combination therapy, the potential impact of ongoing and upcoming clinical trials, and the importance of dosimetry.
  • Tumor Boards: Our sessions will utilize tumor boards to spotlight the pivotal role of PSMA imaging and therapy in the context of prostate cancer patients.

Past Events

The 2025 PSMA & Beyond Conference was a great success! Thank you to all of our sponsors, speakers, and attendees for the incredible support and engagement. Check out the photo gallery for key highlights!